CN Patent

CN101370380A — 化合物

Assigned to SmithKline Beecham Corp · Expires 2009-02-18 · 17y expired

What this patent protects

本发明涉及具有多种治疗用途的新化合物。更具体而言，本发明披露了特别适用于选择性雌激素受体调节的新的对称三苯基化合物。

USPTO Abstract

本发明涉及具有多种治疗用途的新化合物。更具体而言，本发明披露了特别适用于选择性雌激素受体调节的新的对称三苯基化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101370380A
Jurisdiction
CN
Classification
—
Expires
2009-02-18
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.